0001209191-19-058729.txt : 20191203 0001209191-19-058729.hdr.sgml : 20191203 20191203164922 ACCESSION NUMBER: 0001209191-19-058729 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191202 FILED AS OF DATE: 20191203 DATE AS OF CHANGE: 20191203 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hirmand Mohammad CENTRAL INDEX KEY: 0001654482 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38871 FILM NUMBER: 191266286 MAIL ADDRESS: STREET 1: C/O MEDIVATION, INC. STREET 2: 525 MARKET ST., 36TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Turning Point Therapeutics, Inc. CENTRAL INDEX KEY: 0001595893 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 463826166 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10628 SCIENCE CENTER DRIVE, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-926-5251 MAIL ADDRESS: STREET 1: 10628 SCIENCE CENTER DRIVE, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: TP Therapeutics, Inc. DATE OF NAME CHANGE: 20181018 FORMER COMPANY: FORMER CONFORMED NAME: TP Therapeutics, INC DATE OF NAME CHANGE: 20140106 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-12-02 0 0001595893 Turning Point Therapeutics, Inc. TPTX 0001654482 Hirmand Mohammad C/O TURNING POINT THERAPEUTICS, INC. 10628 SCIENCE CENTER DRIVE, STE. 200 SAN DIEGO CA 92121 0 1 0 0 EVP and Chief Medical Officer Stock Option (right to buy) 54.73 2019-12-02 4 A 0 179192 0.00 A 2029-12-01 Common Stock 179192 179192 D 25% of the shares vest on December 2, 2020 and 1/48th of the shares vest monthly thereafter over the next three years. /s/ Annette North, Attorney-in-Fact 2019-12-03